Slow Capital’s GSK GSK Stock Holding History

Slow Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-198	Closed	-$9K	–	216
2020 Q3	$9K	Buy	+198	New	+$9.92K	﹤0.01%	238
2018 Q4	–	Sell	-4,600	Closed	-$231K	–	145
2018 Q3	$231K	Sell	4,600 -322	-7%	-$16.4K	0.1%	144
2018 Q2	$248K	Sell	4,922 -5,360	-52%	-$270K	0.13%	134
2018 Q1	$513K	Sell	10,282 -5,528	-35%	-$257K	0.23%	116
2017 Q4	$724K	Buy	+15,810	New	+$730K	0.38%	89

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Slow Capital's GSK Position: Q4 2020 in Review

Slow Capital sold out of GSK (GSK) in Q4 2020, closing a stake of 198 shares — an estimated $9K sold.

Slow Capital first reported a position in GSK in Q4 2017 and held it in 5 quarters. The position peaked at $724K in Q4 2017. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

Slow Capital reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
Slow Capital sold 198 GSK shares in Q4 2020, an estimated $9K.
Slow Capital first reported a position in GSK in Q4 2017 and held it in 5 quarters.
Slow Capital's GSK position peaked at $724K in Q4 2017.
818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Slow Capital's 13F filing for Q4 2020, filed 11 Feb 2021.